New

North America Immunohistochemistry Market

2021

North America Immunohistochemistry Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Diagnostics and Drug Testing), Product (Antibodies, Equipment, Reagents, and Kits), and End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others)

Publication Month: Nov 2021 | Report Code: TIPRE00025750 | No. of Pages: 150 | Category: Biotechnology | Status: Published

Market Insights

North America Immunohistochemistry Market to Grow at a CAGR of 7.7% to reach US$ 1,405.86 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The North America immunohistochemistry market is expected to grow from US$ 838.05 million in 2021 to US$ 1,405.86 million by 2028; it is estimated to grow at a CAGR of 7.7% from 2021 to 2028.

The US, Canada, and Mexico are economies in North America. Growing incidences of chronic and infectious diseases is expected to escalate the market growth. Immunohistochemistry (IHC) refers to an important application monoclonal and polyclonal antibody for tissue determination and distribution of antigens of particular disease. It is majorly used to detect several infectious disorders like dengue, hepatitis, human immunodeficiency virus (HIV). Chronic medical conditions such as obesity, cancer, diabetes, heart disease, and stroke, are also considered to be the primary major applications of immunohistochemistry that helps in the diagnosis of these diseases. Diabetes is prevailing at a high rate in the geriatric population across the region. The prevalence of diabetes is more in overweight and obese people. The obesity rates have been increasing rapidly in developed as well as developing economies across the region. Factors such as unhealthy lifestyle and sedentary life are among the major for the rise in the number of obese individuals. Cardiovascular diseases (CVDs) include cerebrovascular disease, rheumatic heart disease, coronary heart disease, and other conditions. It is the most significant cause of morbidity and mortality across the region. Furthermore, there has been a rise in cancer incidence and mortality rates all over the region, making cancer the leading cause of death. Such an increase in the incidence of chronic and infectious diseases is expected to create a demand for immunoassay tests around the North America region.

Countries in North America, especially the US, are highly affected due to the COVID-19 outbreak. Various healthcare research centers across the country are focused on COVID-19 treatments. The outbreak pandemic has adversely affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increasing demand for invitro diagnostic products and rising research and development activities in North America. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out amid the outbreak and delayed or prolonged procurement of equipment. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches are expected to pave the way for entirely virtual trials in the future. New technologies, such as mRNA, are expected to drive the pharmaceutical industry. Thus, the market is expected to witness vertical integration and joint ventures in coming years.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America immunohistochemistry market. The North America immunohistochemistry market is expected to grow at a good CAGR during the forecast period.
North America immunohistochemistry market

Get more information on this report :


North America Immunohistochemistry Market Segmentation

North America Immunohistochemistry Market – By Product

  • Equipment
    • Slide Staining Systems
    • Tissue Microarray Systems
    • Tissue Processing Systems
    • Slide Scanners
    • Other Equipment
  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Reagents
    • Histological Stains
    • Blocking and Fixation Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

North America Immunohistochemistry Market – By Application

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
    • Others
  • Drug Testing

North America Immunohistochemistry Market – By End User

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Others

North America Immunohistochemistry Market, by Country

  • US
  • Canada
  • Mexico

North America Immunohistochemistry Market - Companies Mentioned

  • Abcam plc
  • Agilent Technologies, Inc.
  • Bio SB
  • BIO-RAD LABORATORIES INC.
  • Cell Signaling Technology, Inc.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • MERCK KGaA
  • PerkinElmer Inc.
  • THERMO FISHER SCIENTIFIC INC.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Immunohistochemistry Market – By Product

1.3.2 North America Immunohistochemistry Market – By Application

1.3.3 North America Immunohistochemistry Market – By End User

1.3.4 North America Immunohistochemistry Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Immunohistochemistry Market – Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Experts Opinion

5. North America Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Incidences of Chronic and Infectious Diseases

5.1.2 Rising R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Complexities Associated with Immunohistochemistry

5.3 Key Market Opportunities

5.3.1 Growth Opportunities in Several Countries

5.4 Future Trends

5.4.1 Rise of Automation in Immunohistochemistry

5.5 Impact Analysis

6. Immunohistochemistry Market – North America Analysis

6.1 North America Immunohistochemistry Market Revenue Forecast and Analysis

7. North America Immunohistochemistry Market Analysis– By Product

7.1 Overview

7.2 North America Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3 Antibodies

7.3.1 Overview

7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3 Primary Antibodies

7.3.3.1 Overview

7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4 Secondary Antibodies

7.3.4.1 Overview

7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Equipment Market

7.4.1 Overview

7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3 Slide Staining Systems

7.4.3.1 Overview

7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4 Tissue Microarrays

7.4.4.1 Overview

7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5 Tissue Processing Systems

7.4.5.1 Overview

7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6 Slide Scanners

7.4.6.1 Overview

7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7 Other Equipments

7.4.7.1 Overview

7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Reagents Market

7.5.1 Overview

7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3 Histological Stains

7.5.3.1 Overview

7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4 Blocking Sera & Reagents Market

7.5.4.1 Overview

7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5 Chromogenic Substrates Market

7.5.5.1 Overview

7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6 Stabilizers

7.5.6.1 Overview

7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7 Proteolytic Enzymes

7.5.7.1 Overview

7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8 Organic Solvents

7.5.8.1 Overview

7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9 Fixation Reagents

7.5.9.1 Overview

7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10 Diluents

7.5.10.1 Overview

7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Kits Market

7.6.1 Overview

7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8. North America Immunohistochemistry Market Analysis – By Application

8.1 Overview

8.2 North America Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3 Diagnostics

8.3.1 Overview

8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3 Cancer

8.3.3.1 Overview

8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4 Infectious Diseases

8.3.4.1 Overview

8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5 Autoimmune Diseases

8.3.5.1 Overview

8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6 Diabetes Mellitus

8.3.6.1 Overview

8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7 Nephrological Diseases

8.3.7.1 Overview

8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8 Others

8.3.8.1 Overview

8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Drug Testing

8.4.1 Overview

8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9. North America Global Immunohistochemistry Market Analysis– By End User

9.1 Overview

9.2 North America Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3 Hospital & Diagnostic Laboratories

9.3.1 Overview

9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10. North America Immunohistochemistry Market – Country Analysis

10.1 North America Immunohistochemistry Market Revenue and Forecasts To 2028

10.1.1 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1 US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1 US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.2 US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.1.2.1 US Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.1.2.2 US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.1.2.3 US Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.1.3 US Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.1.3.1 US Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.1.4 US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1 Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.2.2.1 Canada Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.2.2.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.2.2.3 Canada Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.2.3 Canada Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.2.3.1 Canada Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.2.4 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.3 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.2 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.3.2.1 Mexico Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.3.2.2 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.3.2.3 Mexico Antibodies Market Revenue and Forecasts To 2028, By Type (US$ Mn)

10.1.1.3.3 Mexico Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.3.3.1 Mexico Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.3.4 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on North America Immunohistochemistry Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic developments

12.3.1 Overview

13. Company Profiles

13.1 Cell Signaling Technology, Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 MERCK KGaA

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 PerkinElmer Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 THERMO FISHER SCIENTIFIC INC.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Abcam plc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 BIO-RAD LABORATORIES INC.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Danaher

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Bio SB

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2. US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. US Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 4. US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 5. US Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6. US Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 7. US Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 8. US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 9. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10. Canada Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 11. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 12. Canada Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13. Canada Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 14. Canada Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 15. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 16. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. Mexico Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 18. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 19. Mexico Antibodies Market Revenue and Forecasts to 2028, By Type (US$ Mn)

Table 20. Mexico Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 21. Mexico Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 22. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 23. Organic Developments Done By Companies

Table 24. Inorganic developments done by Companies

Table 25. Glossary of Terms

LIST OF FIGURES

Figure 1. North America Immunohistochemistry Market Segmentation

Figure 2. North America Immunohistochemistry Market Segmentation, By Country

Figure 3. North America Immunohistochemistry Market Overview

Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5. The US to Show Significant Growth During Forecast Period

Figure 6. North America PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to North America Immunohistochemistry Market

Figure 8. North America Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9. North America Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10. North America Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. North America Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. North America Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. North America Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. North America Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. North America Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. North America Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. North America Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. North America Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. North America Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. North America Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. North America Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. North America Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. North America Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. North America Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. North America Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. North America Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. North America Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. North America Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. North America Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30. North America Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31. North America Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32. North America Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33. North America Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34. North America Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35. North America Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36. North America Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37. North America Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38. North America Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39. North America Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. North America Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. North America Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. North America Immunohistochemistry Market Revenue Overview, by Country (2021) (US$ Mn)

Figure 43. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45. Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. Impact of COVID-19 Pandemic in North American Country Markets

  1. Abcam plc
  2. Agilent Technologies, Inc.
  3. Bio SB
  4. BIO-RAD LABORATORIES INC.
  5. Cell Signaling Technology, Inc.
  6. Danaher
  7. F. HOFFMANN-LA ROCHE LTD.
  8. MERCK KGaA
  9. PerkinElmer Inc.
  10. THERMO FISHER SCIENTIFIC INC.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America immunohistochemistry market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies  
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
TIPRE00025750
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.